Skip to main content
OpenEvidence

OpenEvidence

LimitedContacted

OpenEvidence is available in Syria with limited functionality, as of .

AI-powered medical assistant for clinicians with evidence-based research and clinical guidelines

Last Updated

High-vote services get prioritized for outreach

Progress Timeline

Activity Summary

Partially blocked in Syria, confirmed by community testing in March 2026: one subdomain returns an "Access denied" page from Syrian IPs, the main site loads but the AI assistant returns a usage-limit message, and account registration requires a VPN. A community volunteer emailed the company in March 2026 requesting access; no response has been received.

Contacted Company

A community volunteer emailed OpenEvidence at contact@openevidence.com requesting that service access be enabled for users in Syria. The email referenced the December 2025 OFAC sanctions lift and EU sanctions removal, included links to official U.S. Treasury documentation, and noted that several oth...

Work at OpenEvidence? Know someone who does?

Sanctions are lifted. Most companies just haven't updated their policies. A word from inside OpenEvidence can change that.

Tips for advocating

  • Reach out to legal, compliance, or policy teams.
  • Reference the lifted sanctions.
  • Point to competitors who have already unblocked Syria.

Related Services

Other services in the same categories

AMBOSS

Accessible

Academia.edu

Accessible

Alexa

Blocked

Frequently Asked Questions

OpenEvidence has limited access in Syria. Some features or regions may be restricted. Check this page for the latest status updates.

Many international services blocked access to Syria due to previous sanctions and compliance policies. Even as sanctions are being reviewed, some companies have not yet restored access. Unblock Syria tracks these services and advocates for change.

You can help by voting on this page to show demand, sharing it on social media, and contacting OpenEvidence directly to request they restore access for Syrian users.